Deutsche Bank updates it's 2011 model and introducing 2012 estimates on Chemed Corp CHE. While DB maintains a Hold, it is becoming more optimistic about CHE's capital deployment strategy given recent buyback activity.
Deutsche Bank raises its price target to $67 from $61 to base off of a new out-year forecast -- 7.5x 2012 EV/EBITDA, although DB acknowledges a sum-of-the-parts could support a higher valuation multiple. Our Hold opinion is under-pinned by CHE's relatively modest growth profile and more mature margin structure, offset by strong FCF and flexible balance sheet.
Deutsche Bank's 2011 estimates include Y/Y rev growth of +5.4% to $1.34B, EBITDA growth of +9.8% to $190.4M, and pro forma EPS of $4.68. Deutsche Bank's EPS forecast is above consensus due primarily to its share buyback assumption in which it assumes CHE will repurchase roughly 4% of shares outstanding in 2011.
Deutsche Bank has a $67 PT and Hold rating on CHE
CHE closed Friday at $63.33
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in